Corbus Pharmaceuticals Holdings (CRBP) Change in Account Payables (2013 - 2025)

Corbus Pharmaceuticals Holdings' Change in Account Payables history runs 13 years deep, the most recent figure standing at -$1.3 million for Q3 2025.

• On a quarterly basis, Change in Account Payables fell 165.37% year-over-year to -$1.3 million in Q3 2025; TTM through Sep 2025 was -$107000.0, a 93.2% increase from a year earlier, with the FY2024 full-year figure at $1.6 million, up 55.93% from the prior year.
• Change in Account Payables declined to -$1.3 million in Q3 2025 per CRBP's latest filing, from $175000.0 in the prior quarter.
• Across five years, Change in Account Payables topped out at $3.2 million in Q3 2023 and bottomed at -$3.7 million in Q1 2021.
• The 5-year median for Change in Account Payables is -$759706.0 (2021), against an average of -$282480.6.
• Across the five-year window, Change in Account Payables jumped 493.74% in 2023 and sank 586.81% in 2024, its largest moves.
• Year by year, Change in Account Payables stood at -$759706.0 in 2021, then surged by 229.06% to $980459.0 in 2022, then tumbled by 252.89% to -$1.5 million in 2023, then soared by 211.94% to $1.7 million in 2024, then sank by 176.04% to -$1.3 million in 2025.
• Per Business Quant, the three latest CRBP Change in Account Payables figures stand at -$1.3 million (Q3 2025), $175000.0 (Q2 2025), and -$684000.0 (Q1 2025).